Epoetin SEDICO represents the most
advanced recombinant DNA biotechnology
synthesized in SEDICO pharmaceuticals.
Sabry A.Alaziz Gohar M.D.;ein shams
university
Mohamed Eltohamy Elshazli M.D.;Assiut
University
Salah Saad Naga M.D.;Alexandria University
Omar Yehya El-Khashab M.D.;El Kasr El-Eini
,Cairo University
Mohamed A.Kahder Sobh M.D.;El Mansoura
University
Amin Mohamed Roshdy Soliman M.D.;El Kasr
El-Eini ,Cairo University
Essam Mohamed Khedr M.D.;Nasr Institute &
Wadi El Nil Hospital
Osama A.Elazim Sharaf El Din M.D.;El KAsr
El-Eini ,Cairo University
Ahmed Adel Hasan M.D.;El Zagazig University
Tariq Gamal ElDin Fouad M.D.;Elmaadi Army
Hospital
Tariq Zakaria ElBazz M.D.;El Azhar
University
Mohamed Amr Ayyad M.D.,Nephrology Institute
El matareya
Adel Bakr M.D.;Ghoneim Center El-Mansoura: They approved that Epoetin SEDICO
is an effective treatment of anemia of
end-stage Kidney Disease in patients on
maintenance haemodialysis (ESKD).
How Epoetin Affect
significally in the improvement of
Haemoglobin and Hematocrit?
Epoetin SEDICO shows significant
improvement of Hb. and Hct. values -as shown
in the chart- in:
►Chronic renal
failure
►Chemotherapy
induced anemia
►Surgical
haemorrhage (all types of haemorrhages)
